GIVLAARI sol inj 189 mg/ml flac 1 ml
7680678950017
CH-67895
A16AX
07.99.0.
Reimbursement limitations:
GIVLAARI.01
Pour le traitement des adultes atteints de porphyrie hépatique aiguë (PHA) qui
• ont eu …
1 / 3
google
Details
- Product number
- 6789501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Lösung: givosiranum 189 mg ut givosiranum natricum, natrii hydroxidum, acidum phosphoricum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 11 mg.
Articles (1)
Givlaari 189 mg/ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLU
|
189.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLU
|
- | Substance | WIZUS |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
11.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 43049.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2023
Authorization holder
Alnylam Switzerland GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 67895
- Drug name
- Givlaari, concentrate for solution for injection
- Galenic form
- LSINJ
- ATC Code
- A16AX
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/03/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GIVLAARI sol inj 189 mg/ml flac 1 ml
- Description (DE)
- GIVLAARI Inj Lös 189 mg/ml Durchstf 1 ml
- Market launch
- 29/03/2021
- Narcotic (BTM)
- No
Application methods
SUBC